Royal Bank of Canada upgraded shares of Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Free Report) to a hold rating in a research report report published on Monday, Zacks.com reports.
Recordati Industria Chimica e Farmaceutica Stock Performance
RCDTF opened at $52.25 on Monday. The business has a 50 day simple moving average of $52.22 and a two-hundred day simple moving average of $51.82. Recordati Industria Chimica e Farmaceutica has a one year low of $52.25 and a one year high of $52.25. The firm has a market capitalization of $10.78 billion, a price-to-earnings ratio of 18.80 and a beta of 0.33. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.36 and a quick ratio of 0.95.
Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Get Free Report) last announced its earnings results on Tuesday, July 30th. The company reported $0.70 earnings per share for the quarter. Recordati Industria Chimica e Farmaceutica had a net margin of 17.41% and a return on equity of 30.78%. The firm had revenue of $622.00 million for the quarter.
About Recordati Industria Chimica e Farmaceutica
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.
Featured Stories
- Five stocks we like better than Recordati Industria Chimica e Farmaceutica
- What is a Stock Market Index and How Do You Use Them?
- 3 Momentum Trades for October With Ample Upside Ahead
- Basic Materials Stocks Investing
- Roblox Dips on Short Report—Here’s Why It Could Bounce Back Fast
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 2 Reasons to Jump on Apple Stock Now and 1 Reason to Think Twice
Receive News & Ratings for Recordati Industria Chimica e Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.